Brachytherapy seed manufacturer Theragenics and women's health firm Advanced Radiation Therapy (ART) have agreed that Theragenics will distribute ART's AccuBoost technology for the treatment of early-stage breast cancer.
AccuBoost is a real-time mammography-guided radiation therapy unit that has been used to treat more than 5,000 women after lumpectomies since 2007, according to Theragenics. It is also used as a noninvasive option for accelerated partial-breast irradiation, the company said.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
